Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
about
Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular ComplicationsEvogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes.Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes.Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.
P2860
Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@ast
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@en
type
label
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@ast
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@en
prefLabel
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@ast
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@en
P2093
P2860
P1433
P1476
Beneficial Effects of Evoglipt ...... Adipose Tissue in Obese Mice.
@en
P2093
Chang-Yell Shin
Il-Hoon Jung
Mi-Kyung Kim
Moon-Ho Son
Tae-Hyoung Kim
Yong Sung Sohn
Yu-Na Chae
P2860
P304
P356
10.1371/JOURNAL.PONE.0144064
P407
P577
2015-12-03T00:00:00Z